3/23
08:04 am
mirm
Mirum Pharmaceuticals (MIRM) had its "buy" rating reaffirmed by HC Wainwright. They now have a $130.00 price target on the stock.
Low
Report
Mirum Pharmaceuticals (MIRM) had its "buy" rating reaffirmed by HC Wainwright. They now have a $130.00 price target on the stock.
3/4
12:45 pm
mirm
Rating for MIRM
Medium
Report
Rating for MIRM
2/26
02:37 pm
mirm
Rating for MIRM
Low
Report
Rating for MIRM
2/26
12:11 pm
mirm
Mirum Pharmaceuticals (MIRM) had its "outperform" rating reaffirmed by Leerink Partners.
Low
Report
Mirum Pharmaceuticals (MIRM) had its "outperform" rating reaffirmed by Leerink Partners.
2/26
10:42 am
mirm
Rating for MIRM
Low
Report
Rating for MIRM
2/26
10:42 am
mirm
Rating for MIRM
Low
Report
Rating for MIRM
2/26
09:34 am
mirm
Rating for MIRM
Medium
Report
Rating for MIRM
2/19
07:26 am
mirm
Mirum Pharmaceuticals (NASDAQ:MIRM) was upgraded by analysts at Royal Bank Of Canada to a "moderate buy" rating.
Low
Report
Mirum Pharmaceuticals (NASDAQ:MIRM) was upgraded by analysts at Royal Bank Of Canada to a "moderate buy" rating.
2/19
07:26 am
mirm
Mirum Pharmaceuticals (NASDAQ:MIRM) was upgraded by analysts at Royal Bank Of Canada to a "moderate buy" rating.
Low
Report
Mirum Pharmaceuticals (NASDAQ:MIRM) was upgraded by analysts at Royal Bank Of Canada to a "moderate buy" rating.
2/18
10:34 am
mirm
Rating for MIRM
Low
Report
Rating for MIRM
2/18
10:34 am
mirm
Rating for MIRM
Low
Report
Rating for MIRM
2/17
04:23 pm
mirm
Mirum Pharmaceuticals initiated with an Outperform at RBC Capital
Low
Report
Mirum Pharmaceuticals initiated with an Outperform at RBC Capital
2/17
04:23 pm
mirm
Mirum Pharmaceuticals initiated with an Outperform at RBC Capital
Low
Report
Mirum Pharmaceuticals initiated with an Outperform at RBC Capital
1/30
12:04 pm
mirm
Rating for MIRM
Low
Report
Rating for MIRM
1/30
12:04 pm
mirm
Rating for MIRM
Low
Report
Rating for MIRM
1/20
09:05 am
mirm
Mirum Pharmaceuticals (NASDAQ:MIRM) had its "outperform" rating reaffirmed by analysts at Evercore ISI.
Low
Report
Mirum Pharmaceuticals (NASDAQ:MIRM) had its "outperform" rating reaffirmed by analysts at Evercore ISI.
1/20
09:05 am
mirm
Mirum Pharmaceuticals (NASDAQ:MIRM) had its "outperform" rating reaffirmed by analysts at Evercore ISI.
Low
Report
Mirum Pharmaceuticals (NASDAQ:MIRM) had its "outperform" rating reaffirmed by analysts at Evercore ISI.
1/13
07:17 am
mirm
Mirum Pharmaceuticals (NASDAQ:MIRM) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Low
Report
Mirum Pharmaceuticals (NASDAQ:MIRM) had its "buy" rating reaffirmed by analysts at HC Wainwright.